Saltar al contenido
Merck

Greater muscle protein synthesis and mitochondrial biogenesis in males compared with females during sprint interval training.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology (2014-03-07)
Rebecca L Scalzo, Garrett L Peltonen, Scott E Binns, Mahalakshmi Shankaran, Gregory R Giordano, Dylan A Hartley, Anna L Klochak, Mark C Lonac, Hunter L R Paris, Steve E Szallar, Lacey M Wood, Frederick F Peelor, William E Holmes, Marc K Hellerstein, Christopher Bell, Karyn L Hamilton, Benjamin F Miller
RESUMEN

Improved endurance exercise performance in adult humans after sprint interval training (SIT) has been attributed to mitochondrial biogenesis. However, muscle protein synthesis (MPS) and mitochondrial biogenesis during SIT have not been measured, nor have sex-specific differences. We hypothesized that males and females would have similar rates of MPS, mitochondrial biogenesis, and synthesis of individual proteins during SIT. Deuterium oxide (D2O) was orally administered to 21 adults [11 male, 10 female; mean age, 23±1 yr; body mass index (BMI), 22.8±0.6 kg/m(2); mean± SE] for 4 wk, to measure protein synthesis rates while completing 9 sessions of 4-8 bouts of 30 s duration on a cycle ergometer separated by 4 min of active recovery. Samples of the vastus lateralis were taken before and 48 h after SIT. SIT increased maximum oxygen uptake (VO(2max), males 43.4±2.1-44.0±2.3; females 39.5±0.9-42.5±1.3 ml/kg/min; P=0.002). MPS was greater in the males than in the females in the mixed (~150%; P < 0.001), cytosolic (~135%; P=0.038), and mitochondrial (~135%; P=0.056) fractions. The corresponding ontological clusters of individual proteins were significantly greater in the males than in the females (all P<0.00001). For the first time, we document greater MPS and mitochondrial biogenesis during SIT in males than in females and describe the synthetic response of individual proteins in humans during exercise training.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Sulfato de sodio, ACS reagent, ≥99.0%, anhydrous, granular
Sigma-Aldrich
Sulfato de sodio, ACS reagent, ≥99.0%, anhydrous, powder
Sigma-Aldrich
Yodoacetamida, Single use vial of 56 mg
Sigma-Aldrich
Yodoacetamida, BioUltra
Sigma-Aldrich
Yodoacetamida, ≥99% (NMR), crystalline
Sigma-Aldrich
BIS-TRIS, ≥98.0% (titration)
Sigma-Aldrich
Sulfato de sodio, ReagentPlus®, ≥99.0%
SAFC
BIS-TRIS
Sigma-Aldrich
Sulfato de sodio, puriss., meets analytical specification of Ph. Eur., BP, USP, anhydrous, 99.0-100.5% (calc. to the dried substance)
Sigma-Aldrich
Sulfato de sodio, anhydrous, free-flowing, Redi-Dri, ACS reagent, ≥99%
Sigma-Aldrich
BIS-TRIS, BioUltra, ≥99.0% (NT)
Sigma-Aldrich
BIS-TRIS, BioPerformance Certified, suitable for cell culture, suitable for insect cell culture, ≥98.0%
Sigma-Aldrich
BIS-TRIS, BioXtra, ≥98.0% (titration)
Sigma-Aldrich
Sulfato de sodio, anhydrous, free-flowing, Redi-Dri, ReagentPlus®, ≥99%
SAFC
Yodoacetamida
Sigma-Aldrich
Sulfato de sodio, ≥99.99% trace metals basis
Sigma-Aldrich
Sulfato de sodio, JIS special grade, ≥99.0%
Sigma-Aldrich
Sulfato de sodio, BioUltra, anhydrous, ≥99.0% (T)
Sigma-Aldrich
Sulfato de sodio, BioXtra, ≥99.0%
SAFC
BIS-TRIS
Sigma-Aldrich
Sulfato de sodio, ≥99.0%, suitable for plant cell culture
Sigma-Aldrich
Sulfato de sodio, tested according to Ph. Eur., anhydrous